Safeguard Scientifics, Inc. (NYSE:SFE) tinted gains of +0.76% (+0.1 points) to US$13.3. The volume of 0.08 Million shares climbed down over an trading activity of 81.59 Million shares. EPS ratio determined by looking at last 12 month figures is -3.55. Over the same time span, the stock marked US$14.4 as its best level and the lowest price reached was US$10.65. The corporation has a market cap of US$275.44 Million.

Safeguard Scientifics, Inc. (NYSE:SFE)’s earnings per share has been growing at a -18.2 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at -77.3 percent while most common profitability ratio return on investment (ROI) was 0 percent. The company’s institutional ownership is monitored at 75.9 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 1 think it is Hold. Recently, analysts have updated the overall rating to 2.2. 4 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

AXT, Inc. (NASDAQ:AXTI) is worth US$264.34 Million and has recently risen 0.76% to US$6.65. The latest exchange of 0.24 Million shares is below its average trading activity of 435.52 Million shares. The day began at US$6.55 but the price moved to US$6.55 at one point during the trading and finally capitulating to a session high of US$6.8. The stock tapped a 52-week high of US$10.75 while the mean 12-month price target for the shares is US$11.08.

Currently, the stock carries a price to earnings ratio of 21.8, a price to book ratio of 1.39, and a price to sales ratio of 2.58. For the past 5 years, the company’s revenue has grown 2.2%, while the company’s earnings per share has grown 23.5%. With an institutional ownership near 58.8%, it carries an earnings per share ratio of 0.31.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 1 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 5 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.83.